{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:10:47Z","timestamp":1760746247781,"version":"build-2065373602"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.thromres.2025.109496","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T20:08:07Z","timestamp":1758571687000},"page":"109496","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Bleeding disorders of unknown cause: A conglomeration of disorders with heterogeneous etiology"],"prefix":"10.1016","volume":"255","author":[{"given":"Shrimati","family":"Shetty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiza","family":"Jivani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aniket","family":"Kamble","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shruti","family":"Kharat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kranti","family":"Patil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gurpreet Kaur","family":"Saini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anam","family":"Dhawlarker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shrinath","family":"Kshirsagar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Savita","family":"Rangarajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2025.109496_bb0005","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/hae.14174","article-title":"Bleeding of unknown cause and unclassified bleeding disorders; diagnosis, pathophysiology and management","volume":"26","author":"Thomas","year":"2020","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2025.109496_bb0010","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1538-7836.2010.04105.x","article-title":"Impact of sex, age, race, ethnicity and aspirin use on bleeding symptoms in healthy adults","volume":"9","author":"Mauer","year":"2011","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109496_bb0015","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1182\/asheducation-2009.1.106","article-title":"Low von Willebrand factor: sometimes a risk factor and sometimes a disease","author":"Sadler","year":"2009","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2025.109496_bb0020","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/jth.12248","article-title":"Bleeders, bleeding rates, and bleeding score","volume":"11","author":"Tosetto","year":"2013","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109496_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2024.102625","article-title":"Bleeding disorder of unknown cause: an illustrated review on current practice, knowledge gaps, and future perspectives","volume":"8","author":"Monard","year":"2024","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109496_bb0030","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/j.jtha.2024.03.005","article-title":"ISTH SSC Von Willebrand factor, platelet physiology, and women\u2019s health issues in thrombosis and haemostasis. Standardization of definition and management for bleeding disorder of unknown cause: communication from the SSC of the ISTH","volume":"22","author":"Baker","year":"2024","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109496_bb0035","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3324\/haematol.10816","article-title":"High prevalence of bleeders of unknown cause among patients with inherited mucocutaneous bleeding. A prospective study of 280 patients and 299 controls","volume":"92","author":"Quiroga","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.thromres.2025.109496_bb0040","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/jth.14454","article-title":"Diagnostic utility of the ISTH bleeding assessment tool in patients with suspected platelet function disorders","volume":"17","author":"Adler","year":"2019","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109496_bb0045","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/EJA.0000000000000985","article-title":"Thromboelastometry as a diagnostic tool in mild bleeding disorders: a prospective cohort study","volume":"36","author":"Greguare-Sander","year":"2019","journal-title":"Eur. J. Anaesthesiol."},{"key":"10.1016\/j.thromres.2025.109496_bb0050","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1111\/jth.15492","article-title":"Current practice and registration patterns among United Kingdom Haemophilia Centre Doctors\u2019 Organisation centers for patients with unclassified bleeding disorders","volume":"19","author":"Thomas","year":"2021","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109496_bb0055","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1055\/s-0041-1726344","article-title":"Outcome of surgical interventions and deliveries in patients with bleeding of unknown cause: an observational study","volume":"121","author":"Veen","year":"2021","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109496_bb0060","article-title":"Bleeding disorder of unknown cause & unclassified bleeding disorders at US hemophilia treatment centers","volume":"8","author":"Berkowitz","year":"2023","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109496_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2023.103730","article-title":"Bleeding disorder of unknown cause: results from Iranian study","volume":"62","author":"Zafarani","year":"2023","journal-title":"Transfus. Apher. Sci."},{"key":"10.1016\/j.thromres.2025.109496_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtha.2025.01.011","article-title":"Platelet function analyzer (PFA-100) in patients with mild to moderate bleeding disorders and bleeding disorder of unknown cause","author":"Mehic","year":"2025","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109496_bb0075","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.jtha.2024.11.014","article-title":"Etiology and diagnosis of heavy menstrual bleeding among adolescent and adult patients: a systematic review and meta-analysis of the literature","volume":"23","author":"Comishen","year":"2024","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109496_bb0080","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/hae.13422","article-title":"High proportion of patients with bleeding of unknown cause in persons with a mild- to- moderate bleeding tendency: results from the Vienna bleeding biobank (VIBB)","volume":"24","author":"Gebhart","year":"2018","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2025.109496_bb0085","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/ijlh.13124","article-title":"Characterization of a large cohort of patients with unclassified bleeding disorder; clinical features, management of haemostatic challenges and use of global haemostatic assessment with proposed recommendations for diagnosis and treatment","volume":"42","author":"MacDonald","year":"2019","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.thromres.2025.109496_bb0090","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000286","article-title":"Fundamentals for a systematic approach to mild and moderate inherited bleeding disorders: an EHA consensus report","volume":"3","author":"Rodeghiero","year":"2019","journal-title":"Hemasphere"},{"key":"10.1016\/j.thromres.2025.109496_bb0095","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejim.2020.04.023","article-title":"The discriminatory power of bleeding assessment tools in adult patients with a mild to moderate bleeding tendency","volume":"78","author":"Gebhart","year":"2020","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.thromres.2025.109496_bb0100","doi-asserted-by":"crossref","DOI":"10.1111\/hae.13991","article-title":"Evaluation of thromboelastometry, thrombin generation and plasma clot lysis time in patients with bleeding of unknown cause: a prospective cohort study","volume":"26","author":"Veen","year":"2020","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2025.109496_bb0105","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/hae.13922","article-title":"Diagnostic work up of patients with increased bleeding tendency","volume":"26","author":"Zegers","year":"2020","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2025.109496_bb0110","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.jtha.2023.03.006","article-title":"Risk factors for future bleeding in patients with mild bleeding disorders: longitudinal data from the Vienna bleeding biobank","volume":"21","author":"Mehic","year":"2023","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109496_bb0115","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1016\/j.jtha.2024.05.027","article-title":"Examining variability in the diagnosis and management of people with bleeding disorders of unknown cause: communication from the ISTH SSC subcommittee on von Willebrand factor","volume":"22","author":"Kelly","year":"2024","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109496_bb0120","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/hae.70065","article-title":"Current practice regarding bleeding disorders of unknown cause in the Netherlands: a national survey","volume":"31","author":"Mussert","year":"2025","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2025.109496_bb0125","article-title":"Clinical profile of patients with rare inherited coagulation disorders: a retrospective analysis of 67 patients from northern India","volume":"4","author":"Sharma","year":"2012","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"10.1016\/j.thromres.2025.109496_bb0130","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1111\/j.1538-7836.2005.01663.x","article-title":"The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study","volume":"3","author":"Rodeghiero","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109496_bb0135","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1111\/j.1538-7836.2010.03975.x","article-title":"ISTH\/SSC bleeding assessment tool\u202f: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders","volume":"8","author":"Rodeghiero","year":"2010","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109496_bb0140","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/hae.13089","article-title":"Evaluation of the utility of the ISTH-BAT in haemophilia carriers: a multinational study","volume":"22","author":"James","year":"2016","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2025.109496_bb0145","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/jth.14683","article-title":"Validation of the ISTH\/SSC bleeding assessment tool for inherited platelet disorders: a communication from the platelet physiology SSC","volume":"18","author":"Gresele","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109496_bb0150","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1538-7836.2006.01847.x","article-title":"A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD)","volume":"4","author":"Tosetto","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109496_bb0155","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/j.1538-7836.2011.04265.x","article-title":"Prospective evaluation of the clinical utility of quantitative bleeding severity assessment in patients referred for hemostatic evaluation","volume":"9","author":"Tosetto","year":"2011","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109496_bb0160","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1111\/j.1538-7836.2012.04775.x","article-title":"Prospective evaluation of a pediatric bleeding questionnaire and the ISTH bleeding assessment tool in children and parents in routine clinical practice","volume":"10","author":"Bidlingmaier","year":"2012","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109496_bb0165","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1111\/j.1538-7836.2009.03499.x","article-title":"Evaluation of the diagnostic utility for von Willebrand disease of a pediatric bleeding questionnaire","volume":"7","author":"Bowman","year":"2009","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109496_bb0170","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1111\/hae.15113","article-title":"Evaluating the impact of the self-BAT screening tool on patient outcomes: results of the let\u2019s talk period project","volume":"30","author":"McDonald","year":"2024","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2025.109496_bb0175","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/hae.12503","article-title":"Normal range of bleeding scores for the ISTH-BAT: adult and pediatric data from the merging project","volume":"20","author":"Elbatarny","year":"2014","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2025.109496_bb0180","doi-asserted-by":"crossref","DOI":"10.1182\/bloodadvances.2025016725","article-title":"Effect of age on ISTH-BAT scores and low VWF diagnosis in the Zimmerman program","author":"Atiq","year":"2025","journal-title":"Blood Adv."},{"key":"10.1016\/j.thromres.2025.109496_bb0185","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.jtha.2022.11.045","article-title":"Variability in international society on thrombosis and haemostasis-scientific and standardization committee endorsed bleeding assessment tool (ISTH-BAT) score with normal aging in healthy females: contributory factors and clinical significance","volume":"21","author":"Doherty","year":"2023","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109496_bb0190","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1160\/TH12-04-0244","article-title":"Determinants of bleeding phenotype in adult patients with moderate or severe von Willebrand disease","volume":"108","author":"de Wee","year":"2012","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109496_bb0195","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12681","article-title":"Fibrinolytic assays in bleeding of unknown cause: improvement in diagnostic yield","volume":"6","author":"Valke","year":"2022","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109496_bb0200","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00277-016-2893-6","article-title":"Fibrinolysis in patients with a mild-to-moderate bleeding tendency of unknown cause","volume":"96","author":"Gebhart","year":"2017","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.thromres.2025.109496_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125069","article-title":"Increased plasma clot permeability and susceptibility to lysis are associated with heavy menstrual bleeding of unknown cause: a case-control study","volume":"10","author":"Szczepaniak","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.thromres.2025.109496_bb0210","doi-asserted-by":"crossref","first-page":"5663","DOI":"10.1182\/bloodadvances.2024012855","article-title":"Plasmin generation analysis in patients with bleeding disorder of unknown cause","volume":"8","author":"Mehic","year":"2024","journal-title":"Blood Adv."},{"key":"10.1016\/j.thromres.2025.109496_bb0215","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.pcl.2018.02.009","article-title":"Congenital disorders of platelet function and number","volume":"65","author":"Sharma","year":"2018","journal-title":"Pediatr. Clin. N. Am."},{"key":"10.1016\/j.thromres.2025.109496_bb0220","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1365-2516.2010.02314.x","article-title":"Inherited disorders of platelet function and challenges to diagnosis of mucocutaneous bleeding","volume":"16","author":"Israels","year":"2010","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2025.109496_bb0225","article-title":"UK genotyping and phenotyping of platelets study group","volume":"123","author":"Lordkipanidz\u00e9","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2025.109496_bb0230","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1111\/jth.15687","article-title":"Low COAT platelets are frequent in patients with bleeding disorders of unknown cause (BDUC) and can be enhanced by DDAVP","volume":"20","author":"Segot","year":"2022","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109496_bb0235","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/bloodadvances.2020003265","article-title":"ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease","volume":"5","author":"James","year":"2021","journal-title":"Blood Adv."},{"key":"10.1016\/j.thromres.2025.109496_bb0240","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/j.1538-7836.2006.01823.x","article-title":"Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD","volume":"4","author":"Eikenboom","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109496_bb0245","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1182\/bloodadvances.2020002038","article-title":"Low VWF: insights into pathogenesis, diagnosis, and clinical management","volume":"4","author":"O\u2019Donnell","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.thromres.2025.109496_bb0250","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1182\/blood-2017-05-786699","article-title":"Novel insights into the clinical phenotype and pathophysiology underlying low VWF levels","volume":"130","author":"Lavin","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2025.109496_bb0255","doi-asserted-by":"crossref","first-page":"5302","DOI":"10.1172\/JCI133780","article-title":"A coagulation defect arising from heterozygous premature termination of tissue factor","volume":"130","author":"Schulman","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.thromres.2025.109496_bb0260","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3324\/haematol.2008.004739","article-title":"Alpha1-antitrypsin Pittsburgh in a family with bleeding tendency","volume":"94","author":"Hua","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.thromres.2025.109496_bb0265","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1055\/a-2413-2966","article-title":"Unfavorably altered fibrin clot phenotype in women following postpartum hemorrhage of unknown cause: effect of lower coagulation factors","volume":"125","author":"Pir\u00f3g","year":"2025","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109496_bb0270","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1182\/blood-2014-08-592733","article-title":"A novel mutation in the F5 gene (factor V Amsterdam) associ-ated with bleeding independent of factor V procoagulant function","volume":"125","author":"Cunha","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2025.109496_bb0275","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/hae.14433","article-title":"Thrombomodulin in patients with mild to moderate bleeding tendency","volume":"27","author":"Mehic","year":"2021","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2025.109496_bb0280","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1053\/j.ajkd.2006.03.036","article-title":"Amyloidosis and bleeding: pathophysiology, diagnosis, and therapy","volume":"47","author":"Sucker","year":"2006","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.thromres.2025.109496_bb0285","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.3324\/haematol.2018.193003","article-title":"Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist\u2019s perspective","volume":"103","author":"Kritharis","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.thromres.2025.109496_bb0290","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.blre.2009.06.001","article-title":"Bleeding in the heritable connective tissue disorders: mechanisms, diagnosis and treatment","volume":"23","author":"Malfait","year":"2009","journal-title":"Blood Rev."},{"key":"10.1016\/j.thromres.2025.109496_bb0295","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1111\/hae.15099","article-title":"Low vitamin C status and hypermobility-related disorders in patients with bleeding disorder of unknown cause","volume":"30","author":"Lein\u00f8e","year":"2024","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2025.109496_bb0300","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/hae.12020","article-title":"Suspected collagen disorders in the bleeding disorder clinic: a case-control study","volume":"19","author":"Jackson","year":"2013","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2025.109496_bb0305","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/hae.13800","article-title":"An update on the new classification of Ehlers-Danlos syndrome and review of the causes of bleeding in this population","volume":"25","author":"Jesudas","year":"2019","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2025.109496_bb0310","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/j.jtha.2023.04.004","article-title":"Characterization of bleeding symptoms in Ehlers-Danlos syndrome","volume":"21","author":"Kumskova","year":"2023","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109496_bb0315","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.freeradbiomed.2021.03.017","article-title":"The role of vitamin C in epigenetic cancer therapy","volume":"170","author":"Mikkelsen","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.thromres.2025.109496_bb0320","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/cge.14026","article-title":"Hypermobile Ehlers-Danlos syndrome: a review and a critical appraisal of published genetic research to date","volume":"101","author":"Scicluna","year":"2022","journal-title":"Clin. Genet."},{"key":"10.1016\/j.thromres.2025.109496_bb0325","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.7418","article-title":"Scurvy: an elusive diagnosis","volume":"11","author":"Pope","year":"2023","journal-title":"Clin. Case Reports"},{"key":"10.1016\/j.thromres.2025.109496_bb0330","first-page":"115","article-title":"Blood, sweat and fear: a classification of hematidrosis","volume":"27","author":"Holoubek","year":"1996","journal-title":"J. Med."},{"key":"10.1016\/j.thromres.2025.109496_bb0335","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1161\/hq0202.103997","article-title":"Amount of H antigen expressed on circulating von Willebrand factor is modified by ABO blood group genotype and is a major determinant of plasma von Willebrand factor antigen levels","volume":"22","author":"O\u2019Donnell","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.thromres.2025.109496_bb0340","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.1182\/bloodadvances.2020002452","article-title":"Association of ABO blood group with bleeding severity in patients with bleeding of unknown cause","volume":"4","author":"Mehic","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.thromres.2025.109496_bb0345","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0140-6736(87)91481-4","article-title":"Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium","volume":"2","author":"Radomski","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2025.109496_bb0350","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1542\/peds.90.1.33","article-title":"A role for prostacyclin in bruising symptomatology","volume":"90","author":"Gerrard","year":"1992","journal-title":"Pediatrics"},{"key":"10.1016\/j.thromres.2025.109496_bb0355","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1055\/s-0032-1328881","article-title":"Drugs that affect platelet function","volume":"38","author":"Scharf","year":"2012","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2025.109496_bb0360","first-page":"62","article-title":"Munchausen\u2019s syndrome. A case of factitious hemoptysis","volume":"41","author":"Saed","year":"1999","journal-title":"Panminerva Med."},{"key":"10.1016\/j.thromres.2025.109496_bb0370","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/ijlh.13124","article-title":"Characterization of a large cohort of patients with unclassified bleeding disorder; clinical features, management of haemostatic challenges and use of global haemostatic assessment with proposed recommendations for diagnosis and treatment","volume":"42","author":"MacDonald","year":"2020","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.thromres.2025.109496_bb0375","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1055\/a-2330-9112","article-title":"Utility of global hemostatic assays in patients with bleeding disorders of unknown cause","volume":"44","author":"Mehic","year":"2024","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.thromres.2025.109496_bb0380","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1182\/blood.2018891192","article-title":"Diagnostic high-throughput sequencing of 2396 patients with bleeding, thrombotic, and platelet disorders","volume":"134","author":"Downes","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2025.109496_bb0385","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1111\/jth.14591","article-title":"Utility of repeat testing in the evaluation for von Willebrand disease in pediatric patients","volume":"17","author":"Doshi","year":"2019","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109496_bb0390","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12513","article-title":"Elevated von Willebrand factor levels during heavy menstrual bleeding episodes limit the diagnostic utility for von Willebrand disease","volume":"5","author":"Brown","year":"2021","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109496_bb0395","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jtha.2023.09.010","article-title":"The necessity of repeat testing for von Willebrand disease in adult patients with mild to moderate bleeding disorders","volume":"22","author":"Mehic","year":"2024","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109496_bb0400","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/09537100310001598792","article-title":"Platelet function tests using platelet aggregometry: need for repetition of the test for diagnosis of defective platelet function","volume":"14","author":"Ghosh","year":"2003","journal-title":"Platelets"},{"key":"10.1016\/j.thromres.2025.109496_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2024.102572","article-title":"Periprocedural hemostatic prophylaxis and outcomes in bleeding disorder of unknown cause","volume":"8","author":"Berkowitz","year":"2024","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109496_bb0410","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1111\/jth.15871","article-title":"Outcomes and management of pregnancy in women with bleeding disorder of unknown cause","volume":"20","author":"Castle","year":"2022","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109496_bb0415","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/hae.12811","article-title":"Unclassified bleeding disorders: outcome of haemostatic challenges. Following tranexamic acid and\/or desmopressin","volume":"22","author":"Obaji","year":"2016","journal-title":"Haemophilia"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825002464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825002464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T04:49:02Z","timestamp":1760676542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384825002464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":82,"alternative-id":["S0049384825002464"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109496","relation":{},"ISSN":["0049-3848"],"issn-type":[{"type":"print","value":"0049-3848"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bleeding disorders of unknown cause: A conglomeration of disorders with heterogeneous etiology","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109496","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109496"}}